• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Uniswap Faces Feeswitch Debate Amidst Governance Challenges

chest

Uniswap faces a feeswitch debate that highlights the tension between product success and token value in DeFi, as governance decides on value capture in essential infrastructure.

user avatarMaria Fernandez

Political Discussions Surrounding Bitcoin Reserve Heat Up

chest

The conversation around a potential Bitcoin reserve in the U.S. is gaining traction, especially in the context of political discussions and market speculation.

user avatarGustavo Mendoza

MARA Holdings Expands Its Infrastructure with Major Land Acquisition in Texas

chest

MARA Holdings has announced a significant acquisition of land in Texas to develop a computing campus.

user avatarRajesh Kumar

AMD to Release Fiscal Q2 2026 Financial Results on August 4

chest

AMD will release its fiscal second quarter 2026 financial results on August 4, 2026.

user avatarArif Mukhtar

Wall Street Analysts Raise AMD's Stock Price Targets Ahead of Earnings Report

chest

Wall Street analysts have raised stock price targets for AMD ahead of its earnings report, reflecting optimism about the company's growth potential.

user avatarLuis Flores

Geopolitical Tensions and Economic Risks Loom Over AMD's Earnings Report

chest

Investors are cautious about AMD's earnings report due to rising geopolitical tensions and economic factors.

user avatarMiguel Rodriguez

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.